GPs still prescribe HRT to avoid CVD
A member of the Government's Committee on Safety of Medicines expert advisory group on hormone replacement therapy has reiterated warnings to GPs not to prescribe HRT for preventing cardiovascular disease.
Professor David Purdie told delegates at a Royal Society of Medicine conference in London last week that epidemiologists in the field believed there was still 'wholesale prescribing of HRT for cardiovascular disease' by GPs.
Professor Purdie, head of clinical research at the centre for metabolic bone disease at the University of Hull, told Pulse: 'There's a perception in certain quarters that GPs are using it for this purpose, but the GP community should be reminded it's not a licensed indication for HRT.'
Professor Purdie admitted the abandonment of one arm of the US Women's Health Initiative study this summer was a 'huge disaster for clarity in this field'.
Meanwhile, new results from the UK Million Women Study, published in this month's British Journal of
Obstetrics and Gynaecology, show a third of women aged 50-64 use HRT, with 31 per cent of women with a history of heart disease or hypertension on hormone replacement therapy.